论文部分内容阅读
目的了解兰山区农村适龄妇女宫颈癌、乳腺癌发病情况,为农村适龄妇女预防两癌提供依据。方法 2012年7月—2013年7月以兰山区35~64岁农村户籍在现住址居住3年以上的妇女,自愿参加并且能接受检查者为筛查对象,筛查对接受检查的妇女先进行常规妇科检查,并对所有妇女行宫颈脱落细胞液基细胞学(thinprep cytologic test,TCT)检查;乳腺癌筛查对接受检查的妇女进行乳腺的视、触诊检查,可疑者进行乳腺彩超、钼靶-X线检查。结果在27 283例宫颈癌受检者中筛出未明确意义的不典型鳞状上皮细胞(atypical squamous cells,ASCUS)占2.20%,不典型鳞状上皮细胞-不除外高度鳞状上皮内病变(atypical squamsus cells-cannot exclude HSIL,ASC-H)占0.08%,低度鳞状上皮内病变(low grade squamous intraepithelial lesion,LSIL)占0.44%,高度鳞状上皮内病变(high grade squamous intraepithelial lesion,HSIL)占0.04%,鳞状细胞癌(squmous cell crcinom,SCC)占0.003%,腺癌占0.02%,宫颈管原位癌占0.07%;在28 015例乳腺癌受检者中筛出乳腺增生占10.04%,乳腺纤维腺瘤占2.85%,乳腺导管内乳头状瘤占0.007%,乳腺小叶瘤变占0.01%,导管原位癌占0.018%,微小浸润癌占0.014%,浸润癌占0.024%。结论通过开展宫颈癌和乳腺癌筛查工作,可做到对宫颈癌、乳腺癌的早发现、早诊断、早治疗,保护妇女的生命健康。
Objective To understand the incidence of cervical cancer and breast cancer in rural-age women in Lanshan district and provide evidences for prevention of two cancers in rural women of same age. Methods From July 2012 to July 2013, women who lived in rural areas aged 35-64 years old in Lanshan Rural Area with current domicile for more than 3 years volunteered to participate and were able to accept the examination as screening subjects, and screening women who underwent screening first Routine gynecological examinations were performed on all women with thinprep cytologic test (TCT) of cervical exfoliated cells; Breast cancer screening Visual and palpation examinations of breasts were performed on women under examination and suspicious persons underwent color Doppler ultrasound, Target-X-ray examination. Results The percentage of atypical squamous cells (ASCUS) with undefined significance in 27 283 cases of cervical cancer was 2.20%. The atypical squamous epithelial cells were not significantly different (HSIL) accounted for 0.08%, low grade squamous intraepithelial lesion (LSIL) accounted for 0.44%, high grade squamous intraepithelial lesion (HSIL) ) Accounted for 0.04%, squamous cell carcinoma (SCC) accounted for 0.003%, adenocarcinoma accounted for 0.02%, cervical canal carcinoma in situ accounted for 0.07%; 28 015 cases of breast cancer screening in patients with breast hyperplasia 10.04%, breast fibroadenoma accounted for 2.85%, intraductal papilloma 0.007%, breast lobular tumor 0.01%, ductal carcinoma in situ 0.018%, microinvasive carcinoma 0.014%, invasive carcinoma 0.024%. Conclusion Through the screening of cervical cancer and breast cancer, early detection, early diagnosis and early treatment of cervical cancer and breast cancer can be achieved and the life and health of women can be protected.